-
61
-
62
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trialResearch in context
Published 2025-01-01Subjects: “…Checkpoint inhibitors…”
Get full text
Article -
63
Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Populat...
Published 2025-02-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
64
Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity
Published 2025-01-01Subjects: “…Checkpoint inhibitors…”
Get full text
Article -
65
Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study
Published 2024-12-01Subjects: Get full text
Article -
66
Immunotherapy for Extensive-stage Small Cell Lung Cancer: Research Progress and Future Perspectives
Published 2024-11-01Subjects: Get full text
Article -
67
Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
Published 2021-12-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
68
Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease
Published 2025-01-01Subjects: Get full text
Article -
69
Immune checkpoint inhibitor‐related type 1 diabetes incidence, risk, and survival association
Published 2025-02-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
70
-
71
Resistance mechanisms to immune checkpoint inhibitors: updated insights
Published 2025-01-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
72
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
73
Hepatic sinusoidal obstruction syndrome (SOS) associated with checkpoint inhibitor therapy
Published 2024-12-01Subjects: Get full text
Article -
74
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Published 2025-01-01Subjects: Get full text
Article -
75
-
76
Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting syste...
Published 2024-11-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
77
-
78
Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations
Published 2025-01-01Subjects: Get full text
Article -
79
-
80
Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report
Published 2025-01-01Subjects: Get full text
Article